Related Experiment Video
Updated: May 27, 2026

Cell-Free DNA Integrity Analysis in Urine Samples
Published on: January 5, 2017
Epigenetics of kidney cancer and bladder cancer
Amanda M Hoffman1, Paul Cairns
1Departments of Surgical Oncology & Pathology, W350, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.
Abstract:
This article focuses on the epigenetic alterations of aberrant promoter hypermethylation of genes, and histone modifications or RNA interference in cancer cells. Current knowledge of the hypermethylation of allele(s) in classical tumor suppressor genes in inherited and sporadic cancer, candidate tumor suppressor and other cancer genes is summarized gene by gene. Global and array-based studies of tumor cell hypermethylation are discussed. The importance of standardization of scoring of the methylation status of a gene is highlighted. The histone marks associated with hypermethylated genes, and the miRNAs with dysregulated expression, in kidney or bladder tumor cells are also discussed. Kidney cancer has the highest mortality rate of the genito-urinary cancers. There are management issues associated with the high recurrence rate of superficial bladder cancer, while muscle-invasive bladder cancer has a poor prognosis. These clinical problems are the basis for the translational application of gene hypermethylation in the diagnosis and prognosis of kidney and bladder cancer.
Insights
This study reviews epigenetic alterations, including gene promoter hypermethylation, in cancer. Understanding these changes in kidney and bladder cancers can aid in diagnosis and prognosis.
Area of Science:
- Epigenetics
- Molecular Oncology
- Cancer Genomics
Background:
- Epigenetic alterations, specifically aberrant promoter hypermethylation, are key in cancer development.
- Classical tumor suppressor genes and other cancer-related genes are frequently affected by hypermethylation in both inherited and sporadic cancers.
- Kidney and bladder cancers present significant clinical challenges due to high mortality and recurrence rates.
Purpose of the Study:
- To summarize current knowledge on gene hypermethylation in cancer cells.
- To discuss global and array-based studies of tumor cell hypermethylation.
- To explore the translational application of gene hypermethylation for kidney and bladder cancer diagnosis and prognosis.
Main Methods:
- Review of existing literature on gene hypermethylation, histone modifications, and RNA interference in cancer.
- Gene-by-gene summary of hypermethylation in tumor suppressor and cancer genes.
- Discussion of global and array-based hypermethylation studies.
Main Results:
- Aberrant promoter hypermethylation is a significant epigenetic alteration in cancer cells.
- Histone modifications and microRNAs (miRNAs) also play roles in kidney and bladder tumor cells.
- Standardization of methylation scoring is crucial for accurate assessment.
Conclusions:
- Gene hypermethylation is a critical factor in the pathogenesis of kidney and bladder cancers.
- Translational application of gene hypermethylation can improve diagnosis and prognosis for these cancers.
- Further research into epigenetic modifications is essential for advancing cancer management.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Cancer Prevention
Some...
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

